Page 8 - Pharma Industry

Lupin launches generic rheumatoid arthritis drug 'Leflunomide' in US market

Drug maker Lupin on Wednesday said it has launched Leflunomide tablets, used to treat rheumatoid arthritis, in the US market. The company has launched the product in 10 mg and 20 mg strengths after receiving the approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a statement. The product would be manufactured at drug maker's Pithampur (Unit I) facility in Madhya Pradesh, it added. The Mumbai-based company's product is the generic equivalent of Sanofi-Aventis US LLC's Arava tablets and is indicated for the treatment of adults with active rheumatoid arthritis (RA). As per IQVIA MAT June data, Leflunomide tablets had an annual sales of around USD 42 million in the US.

Pharmacy consolidation may disrupt domestic drug market: Credit Suisse

The report says if chemists are allowed to replace doctor's prescription with a generic drug, firms with high exposure to chronic therapeutic drugs will be impacted more

Glenmark Q1 net jumps over two-fold, revenue up marginally at Rs 2,344.8 cr

"We focussed on controlling costs on all fronts and will continue with these efforts for the remaining part of the financial year," Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said

Cipla witnesses 3 senior-level exits including India biz CEO Nikhil Chopra

The company's rich legacy of care and strong sense of purpose rooted in a culture of meritocracy and high performance standards have made Cipla an employer of choice for several industry leaders

Will continue to focus on growing business faster than market: Sun Pharma

The company's strategy of developing the Specialty business as an additional growth engine has started delivering, with a gradual ramp up in specialty revenues, Shanghvi said

Pharma industry steps up to cure black marketing of Covid-19 drugs

Some firms are now considering starting their own distribution centres in major cities

Pharma industry committed to supplying quality drugs in India, world: IPA

IPA Secretary General Jain said, the Indian pharmaceutical industry has outshone itself as a consistent and reliable supplier of life-saving medicines to India and the world

More drugs may see price revisions as raw material costs, expenses rise

API prices have gone up by 25-30 per cent for some drugs in recent months

US charges generic drug firm Glenmark with conspiracy in price-fixing

Company says it strongly disagreed with the charge, has 'overwhelming evidence' to support its innocence.

Pharmaceuticals body seeks faster clearances of imported goods at ports

A senior official of the ministry of commerce said most of the goods that have to be cleared by the customs came from China

Electronics to urea: China is everywhere in India's consumer industries

Import of mobile phone components during April-February FY20, according to government figures, hit $7.5 billion - of which 25 per cent was from the land of the dragon.

AstraZeneca Covid-19 vaccine to be shared across Europe, says France

The Netherlands also made clear on Monday that the vaccines would be available to all EU countries that sign up to the scheme after Belgium criticised the deal

Covid-19 crisis: WHO says HCQ trials can resume, safety test done

The World Health Organization said Wednesday that it will resume recruiting patients for the hydroxychloroquine arm of a global trial called Solidarity.

Pharma, chemical stocks lead under lockdown, Aurobindo is top performer

Within BSE-500, 79% stocks gave positive returns in two months of lockdown

Pharma export growth in FY20 down to single digit due to Covid: Pharmexcil

Export growth started declining in February and turned negative in March, at -23.24 per cent

Mumbai docs try Biocon and Roche's biologic drugs on critical Covid cases

Two repurposed drugs for rheumatoid arthritis and psoriasis are being tried on over 100 patients in Mumbai

Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22

Pharma traders seek IT rule exemption as retailers pay stockists in cash

They fear scrutiny by tax authorities at a later date, assure that the relaxation will not be misused

Taking a nap, playing ludo: Gujarat pharma hub hit by near-zero exports

Companies finding it tough to source raw materials amid the lockdown

Aurobindo Pharma faces class action suit in US for concealing facts

Aurobindo Pharma allegedly concealed facts about cancer-causing agent NDMA in type-2 diabetes drug metformin